- By insider
CFO of Adaptive Biotechnologies Corp (30-Year Financial, Insider Trades) Chad M Cohen (insider trades) sold 100,000 shares of ADPT on 01/29/2021 at an average price of $56.13 a share. The total sale was $5.6 million.
Adaptive Biotechnologies Corp has a market cap of $7.69 billion; its shares were traded at around $56.190000 with and P/S ratio of 78.04. GuruFocus has detected 1 severe warning sign with Adaptive Biotechnologies Corp. .
CEO Recent Trades:
-
CEO and Chairman Chad M Robins sold 30,000 shares of ADPT stock on 01/28/2021 at the average price of $59.38. The price of the stock has decreased by 5.37% since.
-
CEO and Chairman Chad M Robins sold 8,400 shares of ADPT stock on 01/19/2021 at the average price of $70.43. The price of the stock has decreased by 20.22% since.
CFO Recent Trades:
-
CFO Chad M Cohen sold 100,000 shares of ADPT stock on 01/29/2021 at the average price of $56.13. The price of the stock has increased by 0.11% since.
-
CFO Chad M Cohen sold 100,000 shares of ADPT stock on 01/26/2021 at the average price of $65.05. The price of the stock has decreased by 13.62% since.
-
CFO Chad M Cohen sold 50,000 shares of ADPT stock on 01/20/2021 at the average price of $67.33. The price of the stock has decreased by 16.55% since.
-
CFO Chad M Cohen sold 50,000 shares of ADPT stock on 01/19/2021 at the average price of $68.61. The price of the stock has decreased by 18.1% since.
-
CFO Chad M Cohen sold 50,000 shares of ADPT stock on 01/13/2021 at the average price of $63.41. The price of the stock has decreased by 11.39% since.
Directors and Officers Recent Trades:
-
SVP and General Counsel Stacy L Taylor sold 2,813 shares of ADPT stock on 01/29/2021 at the average price of $56.51. The price of the stock has decreased by 0.57% since.
-
President Julie Rubinstein sold 15,000 shares of ADPT stock on 01/29/2021 at the average price of $56.28. The price of the stock has decreased by 0.16% since.
-
President Julie Rubinstein sold 30,000 shares of ADPT stock on 01/28/2021 at the average price of $57.39. The price of the stock has decreased by 2.09% since.
-
Chief Medical Officer Lance Baldo sold 40,000 shares of ADPT stock on 01/27/2021 at the average price of $58.95. The price of the stock has decreased by 4.68% since.
-
President Julie Rubinstein sold 30,000 shares of ADPT stock on 01/26/2021 at the average price of $65.52. The price of the stock has decreased by 14.24% since.